| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.93B | -54.1% |
| Cost of Revenue | $975.7M | -62.9% |
| Gross Profit | $955.9M | -39.4% |
| R&D Expense | $283.5M | -10.3% |
| SG&A Expense | $497.4M | -34.2% |
| Operating Income | $47.6M | -81.4% |
| Pre-tax Income | $54.9M | +113.4% |
| Income Tax | -$269.4M | -621.1% |
| Net Income | $2.28B |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $754.4M | +33.5% |
| Accounts Receivable | $350.4M | -48.9% |
| Inventory | $310.4M | -57.9% |
| Current Assets | $5.80B | +66.3% |
| Total Assets | $9.37B | +7.1% |
| Current Liabilities | $1.50B | +21.6% |
| Long-term Debt | $7.26B | -21.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $322.9M | +18.2% |
| Capital Expenditures | $70.3M | +177.9% |
| Investing Cash Flow | $1.98B | +3564.3% |
| Financing Cash Flow | -$2.05B | -2374.2% |
| Free Cash Flow | $252.6M | +1.9% |
| +823.8% |
| EPS (Basic) | $10.09 | +666.9% |
| EPS (Diluted) | $9.63 | +641.0% |
| Total Liabilities |
| $9.10B |
| -17.1% |
| Stockholders' Equity | -$1.00B | +70.9% |